[go: up one dir, main page]

NO961242D0 - Process for the preparation of solid dispersions and depots as well as solid medical forms with dihydropyridine-type calcium antagonists - Google Patents

Process for the preparation of solid dispersions and depots as well as solid medical forms with dihydropyridine-type calcium antagonists

Info

Publication number
NO961242D0
NO961242D0 NO961242A NO961242A NO961242D0 NO 961242 D0 NO961242 D0 NO 961242D0 NO 961242 A NO961242 A NO 961242A NO 961242 A NO961242 A NO 961242A NO 961242 D0 NO961242 D0 NO 961242D0
Authority
NO
Norway
Prior art keywords
solid
depots
dihydropyridine
preparation
well
Prior art date
Application number
NO961242A
Other languages
Norwegian (no)
Other versions
NO961242L (en
Inventor
Franc Vrecer
Marija Filipcic-Mocnik
Jozica Gustin
Original Assignee
Krka Tovarna Zdravil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil filed Critical Krka Tovarna Zdravil
Publication of NO961242D0 publication Critical patent/NO961242D0/en
Publication of NO961242L publication Critical patent/NO961242L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961242A 1993-09-28 1996-03-27 Process for the preparation of solid dispersions and depots as well as solid medical forms with dihydropyridine-type calcium antagonists NO961242L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI9300504A SI9300504A (en) 1993-09-28 1993-09-28 Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
PCT/SI1994/000017 WO1995008987A1 (en) 1993-09-28 1994-09-26 Process for preparation of solid disperions and deposits as well as of solid medicinal forms with dihydropyridine type calcium antagonists

Publications (2)

Publication Number Publication Date
NO961242D0 true NO961242D0 (en) 1996-03-27
NO961242L NO961242L (en) 1996-05-09

Family

ID=20431250

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961242A NO961242L (en) 1993-09-28 1996-03-27 Process for the preparation of solid dispersions and depots as well as solid medical forms with dihydropyridine-type calcium antagonists

Country Status (11)

Country Link
EP (1) EP0721329A1 (en)
CZ (1) CZ90096A3 (en)
FI (1) FI961394A0 (en)
HR (1) HRP940611A2 (en)
HU (1) HUT75643A (en)
NO (1) NO961242L (en)
PL (1) PL313712A1 (en)
SI (1) SI9300504A (en)
SK (1) SK37996A3 (en)
WO (1) WO1995008987A1 (en)
YU (1) YU56494A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133052B1 (en) * 1996-04-29 2000-05-01 Almirall Prodesfarma Sa NEW LIQUID PHARMACEUTICAL FORMULATIONS FOR THE ORAL WAY.
US5985248A (en) * 1996-12-31 1999-11-16 Inhale Therapeutic Systems Processes for spray drying solutions of hydrophobic drugs and compositions thereof
ES2125198B1 (en) * 1997-05-13 1999-11-16 Vita Invest Sa FIXED-DOSE ASSOCIATION OF AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR AND AN ANTAGONIST OF THE CALCIUM CHANNELS, PROCEDURE FOR ITS PREPARATION AND USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
ES2334991T3 (en) 2002-03-26 2010-03-18 Teva Pharmaceutical Industries Ltd. FARMACO MICROPARTICLES.
KR20040011248A (en) * 2002-07-30 2004-02-05 환인제약 주식회사 Solid dispersion comprising amlodipine, method thereof and pharmaceutical composition comprising the solid dispersion
LT2705839T (en) 2012-09-10 2018-06-11 Rivopharm Sa Pharmaceutical composition comprising lacidipine and process of preparation
CN104095811A (en) * 2013-04-09 2014-10-15 上海信谊药厂有限公司 Nimodipine nanosuspension and preparation method thereof
CN109010288B (en) * 2018-07-27 2020-12-08 洛阳瑞华动物保健品有限公司 Process for improving stability of dihydropyridine solid preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DE3433239A1 (en) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen SOLID PHARMACEUTICAL PREPARATION CONTAINING NITRENDIPINE AND METHOD FOR THE PRODUCTION THEREOF
FR2613619B1 (en) * 1987-04-07 1993-10-15 Recherche Informatique Pharmacie DRUGS, DIETETIC PRODUCTS OR HYGIENE PRODUCTS IN THE FORM OF POWDER COMPOSITIONS OBTAINED BY ADSORPTION OF ACTIVE INGREDIENTS ON A FAST-DISSOLVING SUGAR
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
JP3110794B2 (en) * 1991-06-05 2000-11-20 ユーシービージャパン株式会社 Preparation containing 1,4-dihydropyridine derivative

Also Published As

Publication number Publication date
HUT75643A (en) 1997-05-28
EP0721329A1 (en) 1996-07-17
FI961394A7 (en) 1996-03-27
SI9300504A (en) 1995-04-30
YU56494A (en) 1997-03-07
HRP940611A2 (en) 1996-10-31
CZ90096A3 (en) 1996-09-11
PL313712A1 (en) 1996-07-22
FI961394A0 (en) 1996-03-27
HU9600741D0 (en) 1996-05-28
WO1995008987A1 (en) 1995-04-06
NO961242L (en) 1996-05-09
SK37996A3 (en) 1997-02-05

Similar Documents

Publication Publication Date Title
NZ241211A (en) 16alpha,17alpha-alkylidenedioxy-11b,21-dihydroxypregan -4-ene-3,20-dione derivatives substituted by halogen in either or both of the 6alpha- or the 9alpha- position; pharmaceutical compositions, methods of preparation and treatment
NO944164D0 (en) Process for the preparation and use of an HCl adsorbent
NO900439D0 (en) PROCEDURE FOR THE TREATMENT OF INORGANIC POWDER.
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
NO964966L (en) Lactobacillus strains of human origin, mixtures and their use
NO961006L (en) Phosphonomononucleic acids, processes for their preparation and use of the compounds
IS3703A7 (en) Method for the preparation of a medicinal chemical composition which is synergistic and cooperative and methods of its use
NZ241210A (en) 16alpha,17alpha-butylidenedioxy-11b, 21-dihydroxypregn-4-ene-3,20-dione derivatives substituted in either or both the 6alpha- and 9alpha- positions by fluorine; pharmaceutical compositions, methods of preparation and treatment
NO913621D0 (en) CEMENT MIXTURE AND PROCEDURE FOR MAKING THE MIXTURE.
FI940874A7 (en) Process for the preparation of lactic acid and lactic acid esters
NO932791L (en) Procedure for the preparation of titanium dioxide
UA41355C2 (en) Agent for treating neuro-aids
NO922426L (en) RELATIONSHIPS WITH CLEANING-INHIBITING PROPERTIES, PROCEDURE FOR THE PREPARATION OF THESE AND THEIR USE
NO961242D0 (en) Process for the preparation of solid dispersions and depots as well as solid medical forms with dihydropyridine-type calcium antagonists
NO306347B1 (en) Eleutherobin and analogues thereof, use of the compound and pharmaceutical preparation containing it
HUP9902415A3 (en) Solid instant-release forms of administration and process for producing the same
IS4158A (en) Process for the preparation of azamacrocyclic or acyclic aminophosphonate esters and their derivatives
FI961378A0 (en) Process for the preparation of N-methyl-3- (1-methyl-4-piperidinyl) -14-indole-5-ethanesulfonamide
NO870104D0 (en) PHARMACEUTICAL PREPARATION WITH CONTINUOUS RELEASE OF THE ACTIVE COMPONENT AND PROCEDURE FOR PRODUCING THEREOF.
AU3660284A (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
DE69209621D1 (en) Selective gas phase chlorination of polychlorinated beta-picolines for the production of 2,3,5,6-tetrachloropyridine and its precursors
WO1994018988A3 (en) Use of heparins for the treatment of inflammatory or immunological diseases
NO921086D0 (en) PROCEDURE FOR THE PREPARATION AND USE OF SUBSTITUTED 2 ', 3'-DIDESOXY-5-TRIFLUORMYTYLURIDINES
NO981798D0 (en) Process for the preparation of solid pharmaceutical forms
NO905520D0 (en) RIFAMYCIN DERIVATIVES AND PROCEDURES FOR THE PREPARATION OF THESE.